Ability to Meet End Goals of Modern Healthcare Drives the Commercial Value of Nanotechnology in Drug Delivery
Ability to meet modern healthcare’s goals of early diagnosis, improved treatment efficacy, personalized medicine, disease prevention and lower costs is poised to drive the global market for Nanotechnology in Drug Delivery to reach US$95.7 billion by 2024 . Nanotechnology is emerging to become a very critical part of the ongoing healthcare reform and healthcare policy management, given the technology’s potential usher in breakthrough effectiveness in healthcare treatment and therapy and reduce costs. The global healthcare system which prospered and developed during the last half a century as a result of the then witnessed period of boom in scientific development, economic progress and social stability, is now facing a period of financial crisis and meltdown. Deficit ridden governments are seeking to impose cost control mechanisms to rationalize escalating healthcare costs. The healthcare industry is entering into a new era of change and paradigm shift in structure. Spiraling ...